Koninklijke Philips PHG
NYSE PHG
$27.74 +0.11 (+0.42%)
At close: Aug 20, 2026 · 11:22 AM UTC

Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026)

Koninklijke Philips (PHG) posted quarterly Non-Current Deferred Tax Liability of $89.5 million for Q2 2026, up 4.04% year-over-year from $86.0 million in Q2 2025, and down 15.99% quarter-over-quarter from $106.5 million in Q1 2026.

Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

Koninklijke Philips' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $89.5 million for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability rose 4.04% year-over-year to $89.5 million; the TTM figure through Jun 2026 stood at $89.5 million (up 4.04% YoY), while the FY2025 annual figure was $108.3 million, up 25.07% from the prior year.
  • Non-Current Deferred Tax Liability for Q2 2026 stood at $89.5 million, down from $106.5 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $116.3 million in Q2 2022, with the low at $73.0 million in Q2 2023.
  • The 5-year median for Non-Current Deferred Tax Liability is $88.0 million (2024), against an average of $90.6 million.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability soared 69.44% in 2022, then sank 37.27% in 2023.
  • Koninklijke Philips' Non-Current Deferred Tax Liability stood at $92.8 million in 2022, then retreated by 17.72% to $76.4 million in 2023, then gained by 13.31% to $86.6 million in 2024, then rose by 25.07% to $108.3 million in 2025, then decreased by 17.32% to $89.5 million in 2026.
  • Business Quant data shows PHG's Non-Current Deferred Tax Liability at $89.5 million in Q2 2026, $106.5 million in Q1 2026, and $108.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.50 Bn 194.89 Bn 7.27 Bn
2 Stryker 130.00 Bn 126.52 Bn 4.50 Bn
3 Medtronic 120.36 Bn 111.14 Bn 6.41 Bn
4 Boston Scientific 74.19 Bn 73.65 Bn 3.85 Bn
5 Edwards Lifesciences 52.73 Bn 48.48 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.13 Bn 32.02 Bn 2.18 Bn
8 Koninklijke Philips 26.52 Bn 23.20 Bn 4.55 Bn
9 Steris 23.23 Bn 22.75 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.39 Bn 18.98 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 89.50 Mn
Jun 30, 2026 89.50 Mn
Mar 31, 2026 106.54 Mn
Mar 31, 2026 106.54 Mn
Dec 31, 2025 108.26 Mn
Dec 31, 2025 108.26 Mn
Sep 30, 2025 90.02 Mn
Sep 30, 2025 90.02 Mn
Jun 30, 2025 86.03 Mn
Jun 30, 2025 86.03 Mn
Mar 31, 2025 83.10 Mn
Mar 31, 2025 83.10 Mn
Dec 31, 2024 86.56 Mn
Dec 31, 2024 86.56 Mn
Jun 30, 2024 78.61 Mn
Jun 30, 2024 78.61 Mn
Dec 31, 2023 76.39 Mn
Dec 31, 2023 76.39 Mn
Jun 30, 2023 72.96 Mn
Jun 30, 2023 72.96 Mn